Holmes Master Issuer plc Publication of Supplementary Prospectus (0284F)

TIDM37XJ

RNS Number : 0284F

Holmes Master Issuer plc

04 March 2020

Holmes Master Issuer

Publication of Supplementary Prospectus

Holmes Master Issuer plc

4 March 2020

HOLMES MASTER ISSUER PLC

RESIDENTIAL MORTGAGE-BACKED NOTE ISSUANCE PROGRAMME

PUBLICATION OF SUPPLEMENTARY PROSPECTUS

The following supplementary prospectus (the Supplementary Prospectus ) has been approved by the UK Financial Conduct Authority and is available for viewing:

Supplementary Prospectus dated 4 March 2020 to the prospectus dated 24 May 2019 relating to the Residential Mortgage-Backed Note Issuance Programme of Holmes Master Issuer plc (the Prospectus ).

To view the full Supplementary Prospectus please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/0284F_1-2020-3-4.pdf

A copy of the Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM.

The Supplementary Prospectus will also be available for viewing via:

http://www.santander.co.uk/uk/about-santander-uk/investor-relations/holmes-master-trust

For further information, please contact:

Medium Term Funding

Santander UK plc

2 Triton Square

Regent's Place

London NW1 3AN

Tel: [phone]

Email: [e-mail]

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Supplementary Prospectus and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries only (as specified in the Prospectus) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from such Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

This publication of the Supplementary Prospectus does not constitute an offer of securities for sale in the United States. The securities described in the Prospectus have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act ), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold in the United States of America or to, or for the benefit of, U.S. persons (as defined in Regulation S of the Securities Act), except to persons that are qualified institutional buyers within the meaning of Rule 144A under the Securities Act, or in transactions that occur outside the United States to persons other than U.S. persons in accordance with Regulation S, unless the securities are registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

Your right to access this service is conditional upon your compliance with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

PSPEALDLELDEEFA

(END) Dow Jones Newswires

March 04, 2020 09:56 ET (14:56 GMT)